
Samsung Biologics, Eli Lilly to establish biotech incubator in Incheon - Yonhap News Agency
Samsung Biologics, Eli Lilly to establish biotech incubator in Incheon Yonhap News Agency
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)Sources
Samsung Biologics, Eli Lilly to establish biotech incubator in Incheon
Samsung Biologics, the biotech arm of Samsung Group, said Tuesday it has signed an agreement with US pharmaceutical giant Eli Lilly and Co. to set up a biotech incubator in the western city of Incheon. Under the partnership, the two companies will establish a new site for Eli Lilly's Lilly Gateway Labs in Songdo, an international business district in the port city, according to Samsung Biologics. The US company launched Lilly Gateway Labs in 2019 to support emerging biotech companies by offering
By The Korea Herald
Read full article →Samsung Biologics, Eli Lilly to establish biotech incubator in Incheon - Yonhap News Agency
Samsung Biologics, Eli Lilly to establish biotech incubator in Incheon Yonhap News Agency
Read full article →


